Our Team

Executive Team


  • 30+ years experience in R&D, marketing and commercializing technology in water, environment, energy, high-tech markets

  • Broad background in polymer science, engineering, chemistry and water treatment

  • Senior management positions at Air Liquide and Nalco


  • 30+ yrs experience developing technologies for chemical & biological defense, health care, and the DoD

  • Former DARPA Program Manager and current Visiting Scholar at the Wyss Institute, Harvard University

  • Co-founder Soft Robotics, Inc. and senior management positions at Physical Sciences and Nano Terra


  • 20+ yrs experience developing technologies for pharmaceutical, drug delivery, med device and chemical & biological defense markets

  • Broad background in medicinal chemistry, polymer and material science

  • Senior management positions at Arsenal Medical, GelTex Pharmaceuticals, Genzyme and Dyax Corp.


  • 25+ years experience in corporate finance, raising capital and investment banking.

  • Completed over 20 M&A and finance transactions including public market capital raises for Cephalon, Alkermes and GelTex

  • Work experience incudes Deutshe Bank, America’s Growth Capital, Cowen & Co.


  • 25+ years experience in intellectual property/corporate law and working in technology startups from founding to exit

  • Advisor to various U.S. & international governments on the role of Federal & State governments and VCs to drive life sciences innovation

  • Work experience includes Kenyon & Kenyon, Anderson Consulting, Surface Logix


Board of Directors


Currently the Woodford L. and Ann A. Flowers University Professor at Harvard University, Dr. George Whitesides’ present research interests include materials science, biophysics, surface science, polyvalency, microfluidics, optics, self-assembly, microfabrication, nanotechnology, and cell surface biochemistry. Professor Whitesides joined Harvard’s Department of Chemistry in 1982 and served as Department Chairman from 1986 to 1989. Prior to joining Harvard, he was a member of the faculty of the Massachusetts Institute of Technology from 1963 to 1982.

Dr. Whitesides has held advisory positions on the National Research Council, National Science Foundation, and the Department of Defense’s Defense Advanced Research Projects Agency (DARPA), and he is a member of the American Academy of Arts and Sciences, National Academy of Sciences, National Academy of Engineering, and the American Philosophical Society, among other organizations. He has received dozens of honors, including the American Chemical Society (ACS) Award in Pure Chemistry (1975), the Arthur C. Cope Award (1995), the DARPA Award for Significant Technical Achievement (1996), the National Medal of Science (1998), the Von Hippel Award (2000), the Dan David Award (2005), the Welch Award (2005), and the Priestley Award (2007).

Dr. Whitesides is a co-founder of companies with a combined market capitalization of over $20 billion. In the early 80s, he co-founded biotechnology company Genzyme, which remains one of the world’s leading biotechnology companies; in 1993 he co-founded GelTex, which was acquired by Genzyme for $1.2 billion; and in 1996, he co-founded Theravance, which went public in 2004 and currently has a $1.1B market capitalization. Professor Whitesides’ more recent ventures include Arsenal Medical.

George M. Whitesides was born in Louisville, Kentucky. He received an A.B. from Harvard University in 1960 and a Ph.D. from the California Institute of Technology in 1964.


Herbert S. Winokur Jr. is Chairman and Chief Executive Officer of Capricorn Holdings, Inc., a private investment firm. Capricorn’s portfolio investments have encompassed companies whose revenues exceeded $3 billion and which employed more than 25,000 people. Capricorn Holdings presently invests in a number of early-stage growth companies and in various hedge funds.

Mr. Winokur’s previous positions include: Senior Executive Vice President, Member of the Office of the President, and Director – Penn Central Corporation; Senior Vice President – Pacific Holding Corporation; Chief Executive Officer of Pinehurst, Incorporated; Vice President – Pennsylvania Company and Buckeye Pipeline Company. Between 1970 and 1974 he co-founded and was Chairman of the Board at ICF, Inc., Washington, D.C. During 1967 to 1970 Mr. Winokur worked as a U.S. Army officer assigned to the Office of the Secretary of Defense, with staff responsibilities for the design of manpower, aircraft, and financial control systems. He also served as a Consultant to the President’s Cabinet Task Force on Oil Import Controls in 1970.

Mr. Winokur serves as a Trustee of the National Humanities Center and of Ithaka Harbors, Inc. He is a member of the Council of Foreign Relations, and has served on a number of public and private company boards. He served as a Fellow of the Harvard Corporation and a Director of Harvard Management Company, which oversees the Harvard University endowment. Mr. Winokur earned AB, AM and PhD degrees from Harvard University, the last in Decision and Control Theory. He lives with his wife Dee in Greenwich, CT.


Oscar Schafer is the Chairman of Rivulet Capital, LLC, a hedge fund that he initially seeded. Oscar is a well-respected Wall Street professional; he has been a longtime participant in the Barron’s Roundtable of top money managers. Previously, Mr. Schafer was a Member of Cumberland Associates, and prior to that he was a General Partner at Steinhardt Partners, which he joined in 1970 as an analyst.

He earned a BA, Magna Cum Laude, at Harvard College in 1961 and an MBA at Harvard Business School in 1964. Mr. Schafer serves on several boards, including Schafer Family Foundation, New York Philharmonic, New York Police Foundation, New York Presbyterian Hospital, University Club, Helsinn Therapeutics, and Izun Pharmaceuticals.


Myer Berlow is a sales and marketing executive with 30 years of experience in global markets. Prior to co-founding Nano Terra, Mr. Berlow was President for Global Marketing Solutions, AOL Time Warner, where he oversaw account services, operations, and the number one interactive marketing sales force in the industry.

Mr. Berlow also directed Interactive Marketing sales across all America Online, Inc. brands and services, including America Online, CompuServe, AOL.COM, Digital City, ICQ, Netscape Netcenter, AOL Moviefone, and Spinner.com. Mr. Berlow grew advertising and commerce revenues to a run-rate of $3 billion. Mr. Berlow joined AOL in 1995 as Vice President for National Accounts, with responsibility for the development of programming and business models for Time Warner, Hachette, Disney, ABC, Times Mirror, and Viacom. He has 25 years of experience in the advertising industry, working at such agencies as McCann-Erickson, Benton and Bowles, FCB, Beber Silverstein, and Griffin Bacal.

Mr. Berlow began his career in media planning and went on to TV programming and network TV buying, becoming Media Director of FCB at the age of 29. Mr. Berlow received his degree in Religion and Political Science from Kenyon College.


Shekar Shetty has worked for over two decades addressing issues in process industries, water and waste, energy, healthcare, and high-tech. Prior to joining Clear Scientific, Shekar worked at Air Liquide, the world’s largest industrial and medical gases company. He was with Air Liquide for over seven years, most recently as Deputy Vice President R&D based in Paris, France. Shekar also worked at Nalco Company, the world’s largest industrial water and waste treatment company based in Naperville, IL, for over 17 years. His last position at Nalco was Vice President R&D.

Mr. Shetty received a BS in Chemical Engineering from the Manipal Institute of Technology, India; an MS in Chemical Engineering from the Illinois Institute of Technology, Chicago, IL; and an MBA from the Kellogg Graduate School of Management at Northwestern University, Evanston, IL. He holds 14 US Patents.